Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Testa

Showing results (541-550 of 588) with videos related to

Pageof 59
Sort By:
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Oncogene|May 18, 2005
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growthDeborah A Altomare, Huihong You, Guang-Hui Xiao, et al.
International Journal of Cancer|November 1, 2008
Genomic events associated with progression of pleural malignant mesotheliomaSergey V Ivanov, Jeremy Miller, Robert Lucito, et al.
Plos One|April 29, 2011
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesisDeborah A Altomare, Craig W Menges, Jinfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Current Pharmaceutical Design|April 15, 2010
Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complicationsG I Forte, G Pilato, L Vaccarino, et al.
The Journal of Urology|November 26, 2015
Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesTimothy Ito, Jianming Pei, Essel Dulaimi, et al.
Molecular Carcinogenesis|April 2, 2004
Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cellsMohamed H Lareef, Quivo Tahin, Joon Song, et al.
International Journal of Cancer|June 29, 2011
ERK2 is essential for the growth of human epithelioid malignant mesotheliomasArti Shukla, Jedd M Hillegass, Maximilian B MacPherson, et al.
Cancer Research|March 5, 2008
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic miceYinfei Tan, Roman A Timakhov, Mamta Rao, et al.
Pageof 59

Showing results (541-550 of 588) with videos related to

Sort By:
Pageof 59
BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.
Oncogene|May 18, 2005
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growthDeborah A Altomare, Huihong You, Guang-Hui Xiao, et al.
International Journal of Cancer|November 1, 2008
Genomic events associated with progression of pleural malignant mesotheliomaSergey V Ivanov, Jeremy Miller, Robert Lucito, et al.
Plos One|April 29, 2011
Losses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesisDeborah A Altomare, Craig W Menges, Jinfei Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Current Pharmaceutical Design|April 15, 2010
Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complicationsG I Forte, G Pilato, L Vaccarino, et al.
The Journal of Urology|November 26, 2015
Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesTimothy Ito, Jianming Pei, Essel Dulaimi, et al.
Molecular Carcinogenesis|April 2, 2004
Chromosome 17p13.2 transfer reverts transformation phenotypes and Fas-mediated apoptosis in breast epithelial cellsMohamed H Lareef, Quivo Tahin, Joon Song, et al.
International Journal of Cancer|June 29, 2011
ERK2 is essential for the growth of human epithelioid malignant mesotheliomasArti Shukla, Jedd M Hillegass, Maximilian B MacPherson, et al.
Cancer Research|March 5, 2008
A novel recurrent chromosomal inversion implicates the homeobox gene Dlx5 in T-cell lymphomas from Lck-Akt2 transgenic miceYinfei Tan, Roman A Timakhov, Mamta Rao, et al.
Pageof 59